Search Results 7201-7210 of 34344 for oral

  1. Examining the efficacy of CBD in patients with functional dyspepsia and normal gastric emptying - Mayo Clinic

    Although nonprescribed cannabis and cannabinoid agents are used in the management of patients with DGBI , evidence derived from clinical trials evaluating the ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) - Mayo Clinic

    * Malabsorption syndrome or other illness that could affect oral absorption * Any other clinically significant comorbidities. Note: Other protocol defined ...

  4. Brian D. Rinker, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral Board ExaminerAmerican Board of Plastic Surgery. 2015 - 2018. Program DirectorPlastic Surgery Residency, University of Kentucky College of Medicine. 2015 ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  6. Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children - Mayo Clinic

    Hormonal contraception (eg, oral contraceptive, contraceptive implant, or injectable hormonal contraceptive). Double-barrier method (eg, condom plus ...

  7. Mouth cancer - Doctors and departments - Mayo Clinic

    Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...

  8. Strategy for Improving Stroke Treatment Response - Mayo Clinic

    Known hereditary or acquired hemorrhagic diathesis, coagulation factor deficiency, or oral anticoagulant therapy with INR >1.7. 15. Platelets <100,000/mm3 ...

  9. Phase 2 Study of VGT-309 in Lung Cancer - Mayo Clinic

    Oral, injectable, implantable, intravaginal, or transdermal hormonal contraceptives, or Intrauterine device or intrauterine hormone-releasing system NOTE ...

  10. A Study to Evaluate the Effectiveness and Safety of Ibrexafungerp in Patients with Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment - Mayo Clinic

    Paschalis Vergidis, M.D.. Closed for enrollment. More information. Publications. Ibrexafungerp: A novel oral glucan synthase inhibitor. Davis MR. M R; Donnelley ...